These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 8605790)

  • 1. Effects of pentoxifylline on circulating cytokine concentrations and hemodynamics in patients with septic shock: results from a double-blind, randomized, placebo-controlled study.
    Zeni F; Pain P; Vindimian M; Gay JP; Gery P; Bertrand M; Page Y; Page D; Vermesch R; Bertrand JC
    Crit Care Med; 1996 Feb; 24(2):207-14. PubMed ID: 8605790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does N-acetyl-L-cysteine influence cytokine response during early human septic shock?
    Spapen H; Zhang H; Demanet C; Vleminckx W; Vincent JL; Huyghens L
    Chest; 1998 Jun; 113(6):1616-24. PubMed ID: 9631802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the immunomodulating agent, pentoxifylline, in the treatment of sepsis in prematurely delivered infants: a placebo-controlled, double-blind trial.
    Lauterbach R; Pawlik D; Kowalczyk D; Ksycínski W; Helwich E; Zembala M
    Crit Care Med; 1999 Apr; 27(4):807-14. PubMed ID: 10321674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock.
    Staudinger T; Presterl E; Graninger W; Locker GJ; Knapp S; Laczika K; Klappacher G; Stoiser B; Wagner A; Tesinsky P; Kordova H; Frass M
    Intensive Care Med; 1996 Sep; 22(9):888-93. PubMed ID: 8905422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of N-acetylcysteine on indirect indicators of tissue oxygenation in septic shock patients: results from a prospective, randomized, double-blind study.
    Spies CD; Reinhart K; Witt I; Meier-Hellmann A; Hannemann L; Bredle DL; Schaffartzik W
    Crit Care Med; 1994 Nov; 22(11):1738-46. PubMed ID: 7956276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CDP571, a humanized antibody to human tumor necrosis factor-alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. CPD571 Sepsis Study Group.
    Dhainaut JF; Vincent JL; Richard C; Lejeune P; Martin C; Fierobe L; Stephens S; Ney UM; Sopwith M
    Crit Care Med; 1995 Sep; 23(9):1461-9. PubMed ID: 7664546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of cytokine evolution (tumor necrosis factor-alpha and interleukin-6) after septic shock, hemorrhagic shock, and severe trauma.
    Martin C; Boisson C; Haccoun M; Thomachot L; Mege JL
    Crit Care Med; 1997 Nov; 25(11):1813-9. PubMed ID: 9366763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.
    Briegel J; Forst H; Haller M; Schelling G; Kilger E; Kuprat G; Hemmer B; Hummel T; Lenhart A; Heyduck M; Stoll C; Peter K
    Crit Care Med; 1999 Apr; 27(4):723-32. PubMed ID: 10321661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory cytokine response in patients with septic shock secondary to generalized peritonitis.
    Riché FC; Cholley BP; Panis YH; Laisné MJ; Briard CG; Graulet AM; Guéris JL; Valleur PD
    Crit Care Med; 2000 Feb; 28(2):433-7. PubMed ID: 10708179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pentoxifylline in severe sepsis: results of a randomized, double-blind, placebo-controlled study.
    Staubach KH; Schröder J; Stüber F; Gehrke K; Traumann E; Zabel P
    Arch Surg; 1998 Jan; 133(1):94-100. PubMed ID: 9438767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial evaluation of human recombinant interleukin-1 receptor antagonist in the treatment of sepsis syndrome: a randomized, open-label, placebo-controlled multicenter trial.
    Fisher CJ; Slotman GJ; Opal SM; Pribble JP; Bone RC; Emmanuel G; Ng D; Bloedow DC; Catalano MA;
    Crit Care Med; 1994 Jan; 22(1):12-21. PubMed ID: 8124953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P; Garcia J; Kouatli A; Kitchen L; Zorka A; Lindsay C; Lawless S; Giroir B
    Chest; 1996 May; 109(5):1302-12. PubMed ID: 8625683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D; Grover R; Anzueto A; Lorente J; Smithies M; Bellomo R; Guntupalli K; Grossman S; Donaldson J; Le Gall JR;
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of L-NAME, an inhibitor of nitric oxide synthesis, on plasma levels of IL-6, IL-8, TNF alpha and nitrite/nitrate in human septic shock.
    Avontuur JA; Stam TC; Jongen-Lavrencic M; van Amsterdam JG; Eggermont AM; Bruining HA
    Intensive Care Med; 1998 Jul; 24(7):673-9. PubMed ID: 9722036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment with tumor necrosis factor-alpha attenuates arterial hypotension and mortality induced by endotoxin in pigs.
    Murphey ED; Traber DL
    Crit Care Med; 2000 Jun; 28(6):2015-21. PubMed ID: 10890657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric mucosal acidosis and cytokine release in patients with septic shock.
    Tamion F; Richard V; Sauger F; Menard JF; Girault C; Richard JC; Thuillez C; Leroy J; Bonmarchand G
    Crit Care Med; 2003 Aug; 31(8):2137-43. PubMed ID: 12973171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of serum cytokine levels by a novel superoxide dismutase mimetic, M40401, in an Escherichia coli model of septic shock: correlation with preserved circulating catecholamines.
    Macarthur H; Couri DM; Wilken GH; Westfall TC; Lechner AJ; Matuschak GM; Chen Z; Salvemini D
    Crit Care Med; 2003 Jan; 31(1):237-45. PubMed ID: 12545022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock.
    Peake SL; Moran JL; Leppard PI
    Crit Care Med; 1996 Aug; 24(8):1302-10. PubMed ID: 8706483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p55 Tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45-2081 Study Group.
    Abraham E; Glauser MP; Butler T; Garbino J; Gelmont D; Laterre PF; Kudsk K; Bruining HA; Otto C; Tobin E; Zwingelstein C; Lesslauer W; Leighton A
    JAMA; 1997 May; 277(19):1531-8. PubMed ID: 9153367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enoximone in contrast to dobutamine improves hepatosplanchnic function in fluid-optimized septic shock patients.
    Kern H; Schröder T; Kaulfuss M; Martin M; Kox WJ; Spies CD
    Crit Care Med; 2001 Aug; 29(8):1519-25. PubMed ID: 11505119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.